close-icon

MHQ: Clinical IntelligencePowered by SurvivorNet

  • health-panel

    Medical History

  • clinical-trial

    Clinical Trials

    ?
Prefer to talk instead of typing?
close-icon

Answers offered are informational and do not constitute medical advice. Learn more

close-icon
Medical History

Review your patient’s information.

What is your gender?

What is your age?

close-icon
Clinical Trials

clinical-icon

filter

Clear List

Ask me anything about your health...

I’m listening

thinking

responding

close-icon close-icon
close-icon
close-icon
close-icon
left-icon Back to Results

Dr. Kim Hirshfield

location-icon

New Brunswick, NJ

MEDICAL Specialty:

Anemia, Breast Cancer, Lobular Carcinoma



195 LITTLE ALBANY ST, NEW BRUNSWICK, NJ, 089011914
66 WEST GILBERT ST, 2ND FLOOR, RED BANK, NJ, 07701
732-235-2465
NPI Number
1841374790
ABOUT

Kim Hirshfield, MD, is an Oncology Specialist in Tinton Falls, NJ. She has received an average 5. 0-star rating from her patients.

Dr. Kim Hirshfield profile image

Published Articles

BRCA genetic testing and treatment patterns for patients with HER2-negative early-stage breast cancer in the US community setting.- 2026
Factors influencing Patient Preferences for BRCA Testing and Adjuvant Therapy in HER2-Negative Early Breast Cancer in the United States: Best-Worst Scaling and Discrete Choice Experiment.- 2026 Mar
Correlation Between Disease-Free Survival Endpoints and Overall Survival in Elderly Patients with Early-Stage HER2-Negative Breast Cancer: A SEER-Medicare Analysis.- 2025 Feb
Real-world perioperative treatment patterns and economic burden of recurrence in early-stage HER2-negative breast cancer: a SEER-Medicare study.- 2025 Dec
Immunotherapy for hormone receptor‒positive HER2-negative breast cancer.- 2024 Dec 6
The Economic Burden of Recurrence in Triple-Negative Breast Cancer Among Working Age Patients in the United States.- 2022 Feb
The role of chromodomain helicase DNA binding protein 1 (CHD1) in promoting an invasive prostate cancer phenotype.- 2021 Jan-Dec
Durable Response to PD1 Inhibitor Pembrolizumab in a Metastatic, Metaplastic Breast Cancer.- 2021 May-Aug
Systemic therapy, survival and end-of-life costs for metastatic triple-negative breast cancer: retrospective SEER-Medicare study of women age ≥65 years.- 2021 Jul
Targetable alterations in invasive pleomorphic lobular carcinoma of the breast.- 2021 Jan 13

Clinical Trials

DNA Changes in Patients With Prostate Cancer
Collecting and Storing Blood Samples From Patients With Cancer
Pegylated Liposomal Doxorubicin Hydrochloride and Carboplatin Followed by Surgery and Paclitaxel in Treating Patients With Triple Negative Stage II-III Breast Cancer

Other Specialists treating Anemia, Breast Cancer, Lobular Carcinoma in New Brunswick, NJ

See All Doctors

Dr. Marissa Botwinick

Specialty: Acute Leukemia, Acute Lymphoid Leukemia, Anemia

My Resources
location-icon

Monmouth Medical Center

My Resources

Dr. Meenakshi Goyal-Khemka

Specialty: Bleeding Disorders, Anemia, Coagulation Disorders

My Resources
location-icon

Monmouth Medical Center

My Resources

Dr. Sujani Surakanti

Specialty: Anemia, Leukocytosis, Vitamin B Deficiency

My Resources
location-icon

Duke Regional Hospital

My Resources

Dr. Richard Drachtman

Specialty: Acute Leukemia, Acute Lymphoid Leukemia, Anemia

My Resources
location-icon

Monmouth Medical Center

My Resources

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider